Basanite (BASA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2025, filed Nov 25, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BASA SEC filings page.
Basanite (BASA) reported $293K in revenue over the twelve months to Sep 30, 2025, up 9.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Basanite's dominant mechanic is margin expansion and cost contraction alongside a liability-heavy balance sheet.
Between FY2023 and FY2024, gross margin expanded from34.0% to60.4% , while lower SG&A helped the operating loss roughly halve. That improvement did not fully reach net income: the operating loss roughly halved, but higher interest expense left net loss at$1.7M .
The FY2024 balance sheet is structurally compressed: total liabilities of
Cash conversion improved in FY2024: operating cash flow was
Financial Health Signals
Basanite does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Basanite scores -354.07, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.5M) relative to total liabilities ($9.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Basanite passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Basanite reported a net loss of $1.7M while operations used $401K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Basanite reported an operating loss of $805K against $925K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Basanite generated $2K in revenue in Q3 2025. This represents a decrease of 97.6% from the same quarter a year earlier. Against the prior quarter it is down 96.0%.
Basanite's EBITDA was -$255K in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 217.4% from the same quarter a year earlier. Against the prior quarter it is up 42.3%.
Basanite reported -$207K in net income in Q3 2025. This represents an increase of 44.8% from the same quarter a year earlier. Against the prior quarter it is up 71.6%.
Basanite earned $0.00 per diluted share (EPS) in Q3 2025. This represents an increase of 100.0% from the same quarter a year earlier.
Cash & Balance Sheet
Basanite held $0 in cash as of Q3 2025; long-term debt is not reported for that period.
Not reported for Q3 2025.
Not reported for Q3 2025.
Margins & Returns
Not shown for Q3 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q3 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q3 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q3 2025.
Capital Allocation
None of these metrics is reported for Q3 2025.
BASA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2K-97.6% | $38K-56.3% | $28K-52.9% | $226K+286.0% | $63K+27.9% | $87K-43.4% | $59K-48.4% | $58K-90.3% |
| Cost of Revenue | $110K+253.0% | $24K-22.0% | $15K+246.5% | $107K+31.5% | $31K-42.0% | $30K-67.8% | $4K-78.4% | $81K-81.6% |
| Gross Profit | -$108K-441.7% | $14K-74.6% | $13K-76.1% | $119K+624.9% | $32K+804.7% | $57K-4.8% | $55K-42.1% | -$23K-113.9% |
| SG&A Expenses | $176K+4.0% | $486K+112.3% | $202K+30.8% | $515K+20.4% | $169K-49.2% | $229K-57.2% | $154K-64.5% | $428K-52.8% |
| Operating Income | -$284K-107.1% | -$472K-173.8% | -$189K-90.3% | -$396K+12.0% | -$137K+59.3% | -$172K+63.8% | -$99K+70.8% | -$451K+41.8% |
| EBITDA | -$255K-217.4% | -$443K-215.3% | -$160K-137.9% | -$396K+5.3% | -$80K+73.6% | -$140K+68.4% | -$67K+78.1% | -$419K+46.0% |
| Interest Expense | $194K+0.4% | $256K+2.1% | $251K+32.7% | $292K+123.3% | $193K+18.7% | $251K+74.2% | $189K+46.3% | $131K+30.3% |
| Income Tax | $0 | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Net Income | -$207K+44.8% | -$728K-72.0% | -$439K-52.5% | -$644K-10.8% | -$374K+25.1% | -$423K+31.7% | -$288K+38.5% | -$581K |
| EPS (Basic) | $0.00+100.0% | $0.00 | -$0.02 | -$0.01 | -$0.03-1400.0% | $0.00 | $0.00 | $0.00+100.0% |
| EPS (Diluted) | $0.00+100.0% | $0.00 | -$0.02 | -$0.01 | -$0.03 | $0.00 | $0.00 | $0.00+100.0% |
| Diluted Shares (Avg) | 268M+2.8% | 260M0.0% | 260M+0.4% | N/A | 260M | 260M+2.5% | 259M+2.3% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
BASA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $125K-42.5% | $184K-57.9% | $111K-75.0% | $266K-52.1% | $218K-71.2% | $438K-41.7% | $443K-46.9% | $555K-39.7% |
| Current Assets | $43K+3.6% | $109K+11.2% | $7K-82.7% | $133K+39.3% | $42K-82.6% | $98K-45.5% | $40K-80.9% | $95K-59.5% |
| Cash & Equivalents | $0-100.0% | $109K+75.6% | $7K+83.2% | $82K+48.8% | $2K-98.0% | $62K+94.8% | $4K-87.7% | $55K+82.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $43K+9.7% | $0-100.0% | $0-100.0% | $51K+26.2% | $40K+0.2% | $36K-28.0% | $36K-46.6% | $40K-40.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $10.1M+20.0% | $9.9M+20.5% | $9.4M+19.8% | $9.1M+18.6% | $8.4M+22.0% | $8.2M+19.8% | $7.8M+2.4% | $7.7M+4.6% |
| Current Liabilities | $10.1M+20.0% | $9.9M+20.5% | $9.4M+19.8% | $9.1M+18.6% | $8.4M | $8.2M+15.0% | $7.8M+2.8% | $7.7M+5.5% |
| Non-Current Liabilities | $0 | $0+100.0% | $0 | $0 | $0+100.0% | -$3+100.0% | $0-100.0% | $0-100.0% |
| Total Equity | -$10.0M-21.7% | -$9.7M-24.9% | -$9.3M-25.5% | -$8.8M-24.1% | -$8.2M-33.5% | -$7.8M-27.4% | -$7.4M-8.4% | -$7.1M-11.0% |
| Retained Earnings | -$59.4M-3.5% | -$59.2M-3.8% | -$58.4M-3.3% | -$58.0M-3.1% | -$57.3M-3.0% | -$57.0M-3.2% | -$56.6M-3.6% | -$56.3M-4.0% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
BASA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$109K+19.0% | -$403K-504.6% | -$75K+41.9% | -$70K+70.2% | -$135K+53.8% | -$67K+85.0% | -$129K-52.6% | -$235K+87.8% |
| Depreciation & Amortization | $29K-49.4% | $29K-9.3% | $29K-9.7% | $29K-9.7% | $57K+77.5% | $32K-0.8% | $32K-0.3% | $32K |
| Stock-Based Compensation | $0 | $0 | $0-100.0% | N/A | $0 | $0 | $15K-76.6% | N/A |
| Investing Cash Flow | $0 | N/A | N/A | N/A | $0 | $0 | $0 | N/A |
| Financing Cash Flow | $88-99.9% | N/A | N/A | $150K-14.3% | $75K-80.0% | $125K-71.9% | $78K-8.5% | $175K-86.3% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
BASA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -7162.3% | 38.0%-27.3pp | 47.2%-45.6pp | 52.7%+91.5pp | 50.5%+59.6pp | 65.3%+26.4pp | 92.8%+10.0pp | -38.8%-65.7pp |
| Operating Margin | -18769.4% | -1242.1% | -674.4% | -175.8% | -218.3% | -198.2% | -166.8% | -771.3% |
| Net Margin | -13650.9% | -1916.7% | -1570.0% | -285.6% | -595.2% | -487.0% | -484.4% | -995.1% |
| Return on Assets | -164.9%+6.8pp | -395.1%-298.4pp | -396.3%-331.3pp | -242.5%-137.6pp | -171.8%-105.6pp | -96.7%-14.1pp | -65.0%-8.9pp | -104.8% |
| Current Ratio | 0.000.0x | 0.010.0x | 0.000.0x | 0.010.0x | 0.01 | 0.010.0x | 0.010.0x | 0.010.0x |
| Asset Turnover | 0.01-0.3x | 0.210.0x | 0.25+0.1x | 0.85+0.7x | 0.29+0.2x | 0.200.0x | 0.130.0x | 0.11-0.6x |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$8.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Basanite BASA | FY2024 | $435K | -$1.7M | N/A | $4.5M | — |
| PANAMERA HOLDINGS CORP PHCI | FY2025 | $241K | -$536K | N/A | $184.7M | — |
| Scandium Interna SCYYF | FY2023 | N/A | $47K | N/A | $42.9M | — |
| American Battery Materials Inc BLTH | FY2025 | N/A | N/A | N/A | $18.9M | — |
Where Basanite Ranks
Frequently Asked Questions
What is Basanite's annual revenue?
Basanite (BASA) reported $435K in total revenue for fiscal year 2024. This represents a 15.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Basanite's revenue growing?
Basanite (BASA) revenue grew by 15.6% year-over-year, from $376K to $435K in fiscal year 2024.
Is Basanite profitable?
No, Basanite (BASA) reported a net income of -$1.7M in fiscal year 2024.
What is Basanite's EBITDA?
Basanite (BASA) had EBITDA of -$684K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Basanite's gross margin?
Basanite (BASA) had a gross margin of 60.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Basanite's operating cash flow?
Basanite (BASA) recorded an outflow of $401K in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are Basanite's total assets?
Basanite (BASA) had $266K in total assets as of fiscal year 2024, including both current and long-term assets.
What is Basanite's current ratio?
Basanite (BASA) had a current ratio of 0.01 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Basanite's return on assets (ROA)?
Basanite (BASA) had a return on assets of -650.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Basanite's P/E ratio?
Basanite (BASA) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2025). The market capitalization is $4.5M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Basanite's price-to-sales ratio?
Basanite (BASA) trades at 15.5x sales, its market capitalization divided by revenue of $293K revenue, trailing 12 months to September 30, 2025. The market capitalization is $4.5M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Basanite's liquidity compare with its operating cash outflow?
At the end of fiscal year 2024, Basanite (BASA) held $82K in cash, cash equivalents and investments, and reported an operating cash outflow of $401K over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Basanite's debt-to-equity ratio negative or not reported?
Basanite (BASA) has negative shareholder equity of -$8.8M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Basanite's Altman Z-Score?
Basanite (BASA) has an Altman Z-Score of -354.07, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Basanite's Piotroski F-Score?
Basanite (BASA) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Basanite's earnings high quality?
Basanite (BASA) reported a net loss of $1.7M while operations used $401K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Basanite cover its interest payments?
Basanite (BASA) reported an operating loss of $805K against $925K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.